EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Mechanistic Targets of Areca catechu Against Neurodegenerative Diseases Through an Integrated Network Pharmacology, Molecular Docking, and Experimental Approaches

Sakawrat Janpaijit, Kanika Verma, Ansella Amanda Epifani Widoyanti iD, Tewin Tencomnao iD, Anchalee Prasansuklab iD

International Journal of Molecular Sciences · 07.06.2026 · 27 (12) · 5169

DOI: 10.3390/ijms27125169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.06.2026. Verfasst von Sakawrat Janpaijit und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Areca, Neurodegenerative Diseases, Neuroprotective Agents, Plant Extracts. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation Fund, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most prevalent neurodegenerative disorders, while the therapeutic efficacy of current drugs for both diseases remains limited, with unfavourable side effects. The fruit of Areca catechu L. (AC) is recognised as a popular chewing item across China and Southeast Asia and has been used for centuries as a traditional remedy, ranging from relieving digestive issues to depression. The neuroprotective role of AC has been underscored in previous studies; however, its mechanisms of action remain unclear. The present study aimed to investigate anti-neurodegenerative mechanisms of AC for the treatment of AD and PD. An integrated approach combining untargeted metabolite profiling, network pharmacology, bioinformatics analysis, and molecular docking was utilised. Experimental validation was performed using in vitro cell-based and in vivo models. The study revealed TNF-α, IL-1β, IL-6, CASP3, MAPK3, and AKT1 as top-ranked hub targets by which AC exerts its action on AD and PD. Enrichment analyses of these genes identified significant biological and functional pathways involved in neuroinflammation, apoptosis, and AD. Experimental validation showed that AC extracts significantly downregulated hub gene expressions in the neuroinflammatory BV-2 microglia cell model and prolonged the survival of the transgenic Caenorhabditis elegans AD model. Docking analysis suggested lucidine B, oxolucidine B, solanocapsine, evodiamine, and liquiritigenin are the principal phytocompounds underlying the neuroprotective properties of AC. The findings revealed the pharmacological mechanisms of AC and highlighted its potential value as an effective, multitargeting natural agent to address challenges in AD and PD therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArecaNeurodegenerative DiseasesNeuroprotective AgentsPlant ExtractsMolecular Docking SimulationAnimalsNetwork PharmacologyHumansCaenorhabditis elegansMiceMicrogliaAlzheimer Disease

Stichwörter der Autor:innen

Alzheimer’s diseaseCaenorhabditis elegansParkinson’s diseaseareca nutmicroglianeuroinflammationtherapeutic mechanisms

Substanzen

Neuroprotective AgentsPlant Extracts

Autor:innen und Institutionen

  • College of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence on Natural Products for Neuroprotection and Anti-Ageing (Neur-Age NatChula), Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Molecular Epidemiology, ICMR-National Institute of Malaria Research, New Delhi 110077, India.
  • Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

ORCID-Profile: Ansella Amanda Epifani Widoyanti, Tewin Tencomnao, Anchalee Prasansuklab

Förderung

  • Thailand Science Research and Innovation Fund, Chulalongkorn University

Zitieren

APA

Janpaijit, S., Verma, K., Widoyanti, A. A. E., Tencomnao, T., & Prasansuklab, A. (2026). Exploring Mechanistic Targets of Areca catechu Against Neurodegenerative Diseases Through an Integrated Network Pharmacology, Molecular Docking, and Experimental Approaches. International Journal of Molecular Sciences, 27(12), 5169. https://doi.org/10.3390/ijms27125169

Vancouver

Janpaijit S, Verma K, Widoyanti AAE, Tencomnao T, Prasansuklab A. Exploring Mechanistic Targets of Areca catechu Against Neurodegenerative Diseases Through an Integrated Network Pharmacology, Molecular Docking, and Experimental Approaches. International Journal of Molecular Sciences. 2026;27(12):5169. doi:10.3390/ijms27125169

BibTeX
@article{Janpaijit2026,
  author = {Janpaijit, Sakawrat and Verma, Kanika and Widoyanti, Ansella Amanda Epifani and Tencomnao, Tewin and Prasansuklab, Anchalee},
  title = {Exploring Mechanistic Targets of Areca catechu Against Neurodegenerative Diseases Through an Integrated Network Pharmacology, Molecular Docking, and Experimental Approaches},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5169},
  doi = {10.3390/ijms27125169}
}
Kostenlos starten →